Immunovant, Inc

RXi Pharmaceuticals Corporation is a discovery-stage biopharmaceutical company that is engaged in the development and potential commercialization of proprietary therapeutics. It conducts various research studies based on RNA interference for the treatment of human diseases. The company offers the rxRNA compound, which is potent and nuclease resistant. Its products have potential uses in the recovery of several inflammatory diseases, such as rheumatoid arthritis, Crohn s disease, atherosclerosis and diabetes. RXi Pharmaceuticals Corporation s oligonucleotide-based product research is sponsored by the Drug Information Association. It additionally works in collaboration with the University of Massachusetts for the development of orally delivered RNA interference therapeutic technologies.

Pfizer, founded in 1849, is one of the largest research-based pharmaceuticals companies in the United States. The company s areas of expertise include human and animal health, and consumer health care products. Its human health segment offers medicines for cardiovascular and metabolic diseases, central nervous system disorders, arthritis and pain, infectious and respiratory diseases, urogenital conditions, cancer, eye diseases and allergies. The consumer health care segment produces and markets various medications for oral care, upper respiratory and gastrointestinal health, tobacco dependence, skin and eye care, and hair growth. The company s animal health division develops products for the prevention and treatment of diseases in livestock and companion animals. The products offered by the division include parasiticides, anti-inflammatories, vaccines, and antibiotics. The company s well-known brands include Sudafed, Listerine, Benadryl, Lipitor, Diflucan, Zithromax, Viagra and Celebrex. It also produces pharmaceutical chemicals and gelatin capsules, and offers contract-manufacturing services. Pfizer has various subsidiaries, including Warner-Lambert, Parke-Davis, and Goedecke, and is headquartered in New York City.

MerciaPharma is a pharmaceutical company based in New York, NY, specializing in the development and distribution of innovative medications for various health conditions. With a focus on research and quality, MerciaPharma aims to provide effective treatment options to improve the well-being of patients and support healthcare professionals in their practices. Generated from their business information